mbiomics GmbH
Germany
- Munich, Bavaria
- 24/03/2023
- Series A
- $13,945,000
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.
- Industry Biotechnology Research
- Website https://mbiomics.com/
- LinkedIn https://www.linkedin.com/company/mbiomics-gmbh/
Related People
Laura FigullaCo Founder
Germany -
Munich, Bavaria
With 15+years of life science entrepreneurial and strategy&transactions consulting experience, including venture capital, M&A, digital transformation and innovation strategy, as well as in-depth industry expertise and strong public relations skills, I am truly passionate about creating company strategies, vision and enabling high-performing teams. My career background allows me to provide strategic, fundraising, and business operations insight for innovative life sciences players, in particular around digital health and biotechnology business models.
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)